All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Approvals & Labels

Click Therapeutics receives FDA authorization for CT-132, a prescription app targeting migraine prevention in adults, used alongside other migraine treatments
Digital therapeutics, migraine - Read more

Recordati's Isturisa (targeting CYP11B1) receives FDA label expansion for endogenous hypercortisolemia in adults with Cushing's syndrome inoperable by surgery
Small molecule, hypercortisolemia, Cushing’s disease - Read more

THE GOOD
Business Development

Sanofi selling Lantus insulin brand in India for ₹2,000 crore ($234 million)
Insulin, diabetes - Read more

PRESENTED BY TLDR BIOTECH
What would you do with 7k+ meticulously tagged biotech & pharma data points?
Free gene-editing data set below!

Over the past year, TLDR Biotech has been collecting and categorizing industry news across approvals, clinical trials, fundraises, partnerships, M&A, politics & policy, and much much more.

Each data point is tagged by drug modality, disease indication, tech area, and even more specific categories. For example:

🔍 Need to track all small molecule fundraises across oncology?

📈 Want a curated list of recent cell therapy clinical trials updates (both the successes and failures)?

💡 Looking for trends in Alzheimer's and Parkinson's disease partnerships?

Here’s a free set of data - gene-editing stories over the last 4 months.

We’re leveraging this resource to build tailored reports and curated insights for select clients—and now you can get full access.

Ready to get access or have questions? Check out our landing page.

✅ More Good News ✅

THE GOOD
Clinical Trials

Telix Pharmaceuticals' TLX101 (targeting LAT1 receptor) shows promising survival results in Ph2 trial for recurrent high-grade glioma
Radiopharm, glioma, brain cancer - Read more

Bristol Myers Squibb advances SystImmune's izalontamab brengitecan (targeting EGFRxHER3, to Ph2/3 trial for first-line triple-negative breast cancer treatment
Bispecific antibody, breast cancer - Read more

THE GOOD
Fundraises

Glycomine raises $115M Series C, developing treatment for rare disease PMM2-congenital disorder of glycosylation
Small molecule, phosphomannomutase 2-congenital disorder of glycosylation - Read more

Sprig Equity $50M inaugural fund, investing in medical technologies to advance patient care.
Venture capital, healthcare investing - Read more

28 Capital (formerly Tiger Gene) launches new investment platform to advance scientific breakthroughs into therapies for patients
Venture capital, biotech Investing, life science investment - Read more

Linden Capital Partners $5.4B Fund VI, healthcare and life science focused private equity firm continuing growth strategy with operational expertise
Healthcare investing, life science investment, private equity - Read more

LucyRx undisclosed investment, pharmacy benefit manager using AI and tech for cost-efficient prescription care
Pharmacy Benefit Managers, AI - Read more

Science Corporation raises $100M, adding to $186M, to advance BCI technology for vision, communication, and cognition restoration
Implant, medical device, geographic atrophy, age-related macular degeneration (AMD) - Read more

Maven Bio $3.1M Seed, AI platform for biopharma strategy and BD research, led by Stephen Pagliuca's family office
AI, software, intelligence - Read more

THE GOOD
Investments

Dutch cabinet envisions Netherlands as global biotech leader by 2040, investing €1.3 billion ($1.48 billion) to accelerate innovations to market
Biotech ecosystem - Read more

THE GOOD
Mergers & Acquisitions

GeneDx to acquire AI-powered genomic interpretation company Fabric Genomics for up to $51 million by Q2 2025
AI, genomics, precision medicine, disease screening - Read more

Biopharmaceutical firm Theratechnologies announces open, non-exclusive sale process with special committee oversight following Future Pak proposal
Monoclonal antibody, peptide drug conjugate, hormone, human immunodeficiency virus (HIV), HIV-associated lipodystrophy - Read more

RadNet to acquire iCad's AI mammography software for $103M, integrating it into DeepHealth subsidiary to enhance breast screening
Imaging, AI, software, mammography - Read more

Bruker acquires majority stake in RECIPE, a European provider of diagnostic kits for therapeutic drug monitoring
Reagents, diagnostics - Read more

THE GOOD
Partnerships

Chime Biologics, Polpharma Biologics, partnering for end-to-end biosimilar development and manufacturing for global market
CDMO (Contract Development & Manufacturing Organization), biologics manufacturing, biosimilar, manufacturing partnership - Read more

M42, Juvenescence, strategic partnership combining AI platforms to develop longevity drugs and identify new targets
AI, longevity medicine, drug discovery, drug development - Read more

Recursion Pharmaceuticals, HealthVerity, partnership integrates real-world data to enhance clinical trial design and accelerate therapeutic development
Clinical trial-focused, software, clinical trial design, real world data - Read more

Akeso, Innovent Biologics, partnering to test PD-1/VEGF antibody and oncolytic virus against colorectal cancer liver metastases
Oncolytic virus, bispecific Antibody, clinical development, colorectal cancer - Read more

THE GOOD
Politics & Policy

WHO member countries draft agreement on international pandemic response guidelines to avoid repeating COVID-19 mistakes
World Health Organization (WHO), pandemic preparedness, COVID-19 - Read more [Paywall]

THE GOOD
Product Launches

Creative Biogene launches advanced CRISPR library screening service for efficient target gene identification and function analysis
CRISPR, Cas9, gene-editing - Read more

Profluent unveils ProGen3 protein models, demonstrating scaling laws for AI in biological design like those seen in language models
AI, drug design, biology foundational model - Read more

THE GOOD
Regulatory

CDC panel unanimously recommends RSV vaccine for high-risk adults aged 50-59, potentially boosting sales for vaccine makers
Centers for Disease Control and Prevention (CDC), respiratory syncytial virus (RSV), vaccine - Read more

THE GOOD
Strategic Plans

Abbott plans to offset tariff costs by leveraging its global manufacturing network of 90 sites
Tariffs, medical device - Read more

THE BAD
Clinical Trials

Novartis terminates Ph2 trial of QUC398 (ADAMTS-5 inhibitor) for knee osteoarthritis due to insufficient pain relief
Undisclosed modality, osteoarthritis - Read more

THE BAD
Earnings & Finances

J&J forecasts $400M impact from global tariffs, mainly affecting its US medical device exports to China
Big pharma earnings, tariffs, medtech - Read more

THE BAD
Layoffs

Illumina cuts over 300 jobs in latest round of layoffs
Next-generation sequencing (NGS) - Read more [Paywall]

THE BAD
Mergers & Acquisitions

Ayrmid getting cold feet? Misses deadline to submit binding $45M takeover bid for bluebird bio, leaving the beleaguered gene therapy innovator with SK Capital and Carlyle's $30M offer
Gene therapy, sickle cell disease, beta thalassemia, early active cerebral adrenoleukodystrophy (CALD) - Read more

THE BAD
Politics & Policy

EU and US pharma companies demand regulatory relief (and monetary compensation) from European Commission if they’re to stay in the EU, and Trump admin-imposted industry-specific tariffs loom
Tariffs, drug pricing - Read more

RFK Jr. claims he'll soon identify environmental causes of rising autism rates, but researchers remain skeptical of announced studies
Autism spectrum disorder, vaccine hesitancy - Read more [Paywall]

THE BAD
Regulatory

GeoVax's Project NextGen funding ends April 2025, but development continues on COVID-19 vaccine targeting immunocompromised populations
Biomedical Advanced Research and Development Authority (BARDA), federal funding, COVID-19, Mpox (monkeypox), smallpox, gene therapy, adeno-associated virus (AAV), head & neck cancer - Read more

THE BAD
Strategic Plans

Investor Soleus urges cash-strapped Essa Pharma to liquidate and return remaining funds to shareholders after prostate cancer trial halt
Small molecule, prostate cancer - Read more

THE UGLY
Lawsuits

Class-action lawsuit against Salvation Army proceeds for denying addiction medications in their treatment facilities
Opioid use disorder, treatment denial lawsuit - Read more [Paywall]

THE UGLY
Public Health

CDC struggles to find resources for measles outbreak in Texas, which has already killed two children despite vaccine availability
Centers for Disease Control and Prevention (CDC), measles, infectious disease outbreak, infectious disease - Read more

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here